Olga S. Plekhanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olga S. Plekhanova has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Vsevolod Arsen'EVich Tkachuk
Lomonosov Moscow State University
19 shared publications - Yelena V. Parfyonova
National Medical Research Center of Cardiology named after academician E.I. Chazov, Moscow, Russia
7 shared publications - Bradford C. Berk
Aab Cardiovascular Research Institute, University of Rochester Medical Center, Rochester, USA
6 shared publications E V Parfenova
5 shared publicationsE. V. Parfenova
Russian Cardiology Research-and-Production Complex, Ministry of Health of the Russian Federation
5 shared publicationsAlex Bobik
4 shared publications
Latest Publications
- Open Access
- 30 April 2019
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 10, 493
Oligonucleotide Microarrays Identified Potential Regulatory Genes Related to Early Outward Arterial Remodeling Induced by Tissue Plasminogen Activator
Constrictive vascular remodeling limiting blood flow, as well as compensatory outward remodeling, has been observed in many cardiovascular diseases; however, the underlying mechanisms regulating the remodeling response of the vessels remain unclear. Plasminogen activators (PA) are involved in many of the processes of vascular remodeling. We have shown previously that increased levels of tissue-type PA (tPA) contributes to outward vascular remodeling. To elucidate the mechanisms involved in the induction of outward remodeling we characterized changes in the expression profiles of 8799 genes in injured rat carotid arteries 1 and 4 days after recombinant tPA treatment compared to vehicle. Periadventitial tPA significantly increased lumen size and vessel area, encompassed by the external elastic lamina, at both one and 4 days after treatment. Among 41 differentially expressed known genes 1 day after tPA application, five genes were involved in gene transcription, five genes were related to the regulation of vascular tone [for example, thromboxane A2 receptor (D32080) or non-selective-type endothelin receptor (S65355)], and eight genes were identified as participating in vascular innervation [for example, calpain (D14478) or neural cell adhesion molecule L1 (X59149)]. Four days after injury in tPA-treated arteries, four genes, regulating vascular tone, were differentially expressed. Thus, tPA promotes outward arterial remodeling after injury, at least in part, by regulating expression of genes in the vessel wall related to function of the nervous system and vascular tone.
- 30 April 2019
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 10, 493
Open AccessOligonucleotide Microarrays Identified Potential Regulatory Genes Related to Early Outward Arterial Remodeling Induced by Tissue Plasminogen Activator
Constrictive vascular remodeling limiting blood flow, as well as compensatory outward remodeling, has been observed in many cardiovascular diseases; however, the underlying mechanisms regulating the remodeling response of the vessels remain unclear. Plasminogen activators (PA) are involved in many of the processes of vascular remodeling. We have shown previously that increased levels of tissue-type PA (tPA) contributes to outward vascular remodeling. To elucidate the mechanisms involved in the induction of outward remodeling we characterized changes in the expression profiles of 8799 genes in injured rat carotid arteries 1 and 4 days after recombinant tPA treatment compared to vehicle. Periadventitial tPA significantly increased lumen size and vessel area, encompassed by the external elastic lamina, at both one and 4 days after treatment. Among 41 differentially expressed known genes 1 day after tPA application, five genes were involved in gene transcription, five genes were related to the regulation of vascular tone [for example, thromboxane A2 receptor (D32080) or non-selective-type endothelin receptor (S65355)], and eight genes were identified as participating in vascular innervation [for example, calpain (D14478) or neural cell adhesion molecule L1 (X59149)]. Four days after injury in tPA-treated arteries, four genes, regulating vascular tone, were differentially expressed. Thus, tPA promotes outward arterial remodeling after injury, at least in part, by regulating expression of genes in the vessel wall related to function of the nervous system and vascular tone.
- Open Access
- 1 September 2016
- Published by Elsevier in European Journal of Cell Biology
- Vol. 95 (9) , 295-310
Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching
- 1 September 2016
- Published by Elsevier in European Journal of Cell Biology
- Vol. 95 (9) , 295-310
Open AccessUrokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching
- 1 August 2015
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 74, 63-70
Non-viral transfer of BDNF and uPA stimulates peripheral nerve regeneration
- 1 August 2015
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 74, 63-70
Non-viral transfer of BDNF and uPA stimulates peripheral nerve regeneration
- 27 July 2015
- Published by Bionika Media in Kardiologiia
- Vol. 7_2015 (7) , 63-77
Mechanisms of Vascular Remodeling Following Arterial Injury
Arterial remodeling is the process of adaptation of the vessel comprising multiple structural and functional alterations of the vascular wall that occur in disease, trauma or aging. Arterial remodeling is accelerated in conditions that adversely affect the structural and functional balance of the vascular system, such as hypertension, atherosclerosis, kidney disease, inflammatory diseases, genetic abnormalities, and mechanical damage. Pathological changes in the vascular wall lead to organ damage and, ultimately, death. The aim of this paper is to review the various factors and complex mechanisms, which underlie negative arterial remodeling after mechanical injury and data indicating on the key role of the urokinase plasminogen activator in this process.
- 27 July 2015
- Published by Bionika Media in Kardiologiia
- Vol. 7_2015 (7) , 63-77
Mechanisms of Vascular Remodeling Following Arterial Injury
Arterial remodeling is the process of adaptation of the vessel comprising multiple structural and functional alterations of the vascular wall that occur in disease, trauma or aging. Arterial remodeling is accelerated in conditions that adversely affect the structural and functional balance of the vascular system, such as hypertension, atherosclerosis, kidney disease, inflammatory diseases, genetic abnormalities, and mechanical damage. Pathological changes in the vascular wall lead to organ damage and, ultimately, death. The aim of this paper is to review the various factors and complex mechanisms, which underlie negative arterial remodeling after mechanical injury and data indicating on the key role of the urokinase plasminogen activator in this process.
- 17 March 2015
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 158 (5) , 700-704
Molecular Modeling as a New Approach to the Development of Urokinase Inhibitors
Proteolytic activity of urokinase plays an important role in negative remodeling of blood vessels, restenosis, tumor angiogenesis, and metastasizing, which necessitates the development of selective urokinase inhibitors. Using methods of computer modeling (docking, post processing, and direct docking) and quantum chemistry, we selected substances from the large compound database, analyzed their structures, and experimentally verified their inhibitor activity. New urokinase inhibitor candidates were proposed based on the theoretical predictions and experimental verification of compound activities. The process of modifying urokinase inhibitors based on (benzothiazol-3-yl)guanidine was developed. A new urokinase inhibitor (5-brom-benzothiazol-3-yl)guanidine, that can be effective for regulation of vascular remodeling and tumor angiogenesis, was created.
- 17 March 2015
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 158 (5) , 700-704
Molecular Modeling as a New Approach to the Development of Urokinase Inhibitors
Proteolytic activity of urokinase plays an important role in negative remodeling of blood vessels, restenosis, tumor angiogenesis, and metastasizing, which necessitates the development of selective urokinase inhibitors. Using methods of computer modeling (docking, post processing, and direct docking) and quantum chemistry, we selected substances from the large compound database, analyzed their structures, and experimentally verified their inhibitor activity. New urokinase inhibitor candidates were proposed based on the theoretical predictions and experimental verification of compound activities. The process of modifying urokinase inhibitors based on (benzothiazol-3-yl)guanidine was developed. A new urokinase inhibitor (5-brom-benzothiazol-3-yl)guanidine, that can be effective for regulation of vascular remodeling and tumor angiogenesis, was created.
- 1 May 2014
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 157 (1) , 18-21
Urokinase Stimulates Production of Matrix Metalloproteinase-9 in Fibroblasts with Involvement of Reactive Oxygen Species
In cultured fibroblasts, urokinase stimulated expression of MMP-9 and generation of ROS, while antioxidant ebselen abolished the stimulating effect of urokinase on MMP-9 expression. sTNF-α produced similar and more pronounced stimulating effect. The data showed that urokinase could regulate MMP-9 expression via ROS generation in fibroblasts, which can play an important role in stimulation of their migration and development of constrictor (negative) vascular remodeling due to thickening of the adventitia.
- 1 May 2014
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 157 (1) , 18-21
Urokinase Stimulates Production of Matrix Metalloproteinase-9 in Fibroblasts with Involvement of Reactive Oxygen Species
In cultured fibroblasts, urokinase stimulated expression of MMP-9 and generation of ROS, while antioxidant ebselen abolished the stimulating effect of urokinase on MMP-9 expression. sTNF-α produced similar and more pronounced stimulating effect. The data showed that urokinase could regulate MMP-9 expression via ROS generation in fibroblasts, which can play an important role in stimulation of their migration and development of constrictor (negative) vascular remodeling due to thickening of the adventitia.
- 1 April 2014
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 156 (6) , 756-759
Proteolytically Inactive Recombinant Forms of Urokinase Suppress Migration of Endothelial Cells
- 1 April 2014
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 156 (6) , 756-759
Proteolytically Inactive Recombinant Forms of Urokinase Suppress Migration of Endothelial Cells
- Open Access
- 1 January 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-15
Application of Molecular Modeling to Urokinase Inhibitors Development
Urokinase-type plasminogen activator (uPA) plays an important role in the regulation of diverse physiologic and pathologic processes. Experimental research has shown that elevated uPA expression is associated with cancer progression, metastasis, and shortened survival in patients, whereas suppression of proteolytic activity of uPA leads to evident decrease of metastasis. Therefore, uPA has been considered as a promising molecular target for development of anticancer drugs. The present study sets out to develop the new selective uPA inhibitors using computer-aided structural based drug design methods. Investigation involves the following stages: computer modeling of the protein active site, development and validation of computer molecular modeling methods: docking (SOL program), postprocessing (DISCORE program), direct generalized docking (FLM program), and the application of the quantum chemical calculations (MOPAC package), search of uPA inhibitors among molecules from databases of ready-made compounds to find new uPA inhibitors, and design of new chemical structures and their optimization and experimental examination. On the basis of known uPA inhibitors and modeling results, 18 new compounds have been designed, calculated using programs mentioned above, synthesized, and testedin vitro. Eight of them display inhibitory activity and two of them display activity about 10 μM.
- 1 January 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-15
Open AccessApplication of Molecular Modeling to Urokinase Inhibitors Development
Urokinase-type plasminogen activator (uPA) plays an important role in the regulation of diverse physiologic and pathologic processes. Experimental research has shown that elevated uPA expression is associated with cancer progression, metastasis, and shortened survival in patients, whereas suppression of proteolytic activity of uPA leads to evident decrease of metastasis. Therefore, uPA has been considered as a promising molecular target for development of anticancer drugs. The present study sets out to develop the new selective uPA inhibitors using computer-aided structural based drug design methods. Investigation involves the following stages: computer modeling of the protein active site, development and validation of computer molecular modeling methods: docking (SOL program), postprocessing (DISCORE program), direct generalized docking (FLM program), and the application of the quantum chemical calculations (MOPAC package), search of uPA inhibitors among molecules from databases of ready-made compounds to find new uPA inhibitors, and design of new chemical structures and their optimization and experimental examination. On the basis of known uPA inhibitors and modeling results, 18 new compounds have been designed, calculated using programs mentioned above, synthesized, and testedin vitro. Eight of them display inhibitory activity and two of them display activity about 10 μM.
- 22 September 2013
- Published by Springer Nature in Heart and Vessels
- Vol. 29 (5) , 611-618
Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty
- 22 September 2013
- Published by Springer Nature in Heart and Vessels
- Vol. 29 (5) , 611-618
Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty
- 1 May 2009
- Vol. 95 (5) , 442-64
[Regulation of growth and remodeling of blood vessels: the unique role of urokinase].
Urokinase-plasminogen activator (uPA) is a multifunctional fibrinolytic protein activating growth factors, inducing proteolytic cascades, modulating cytokines, regulating receptor shedding, cellular phenotypic modulation and protein expression. These mechanisms underlie the ability of uPA to stimulate the key processes of vascular remodelling, atherosclerosis progression, restenosis and angiogenesis, -- cell migration and proliferation. We summarized data received by us and others concerning the role of uPA in blood vessel remodelling and growth. At the present stage, the uPA may be considered as a perspective target for influences directed on both the prevention of negative arterial remodelling and restenosis as well as the stimulation of vessel growth at ischemic diseases.
- 1 May 2009
- Vol. 95 (5) , 442-64
[Regulation of growth and remodeling of blood vessels: the unique role of urokinase].
Urokinase-plasminogen activator (uPA) is a multifunctional fibrinolytic protein activating growth factors, inducing proteolytic cascades, modulating cytokines, regulating receptor shedding, cellular phenotypic modulation and protein expression. These mechanisms underlie the ability of uPA to stimulate the key processes of vascular remodelling, atherosclerosis progression, restenosis and angiogenesis, -- cell migration and proliferation. We summarized data received by us and others concerning the role of uPA in blood vessel remodelling and growth. At the present stage, the uPA may be considered as a perspective target for influences directed on both the prevention of negative arterial remodelling and restenosis as well as the stimulation of vessel growth at ischemic diseases.